About Company
BridgeBio Pharma is a biotechnology company dedicated to developing breakthrough medicines for genetic diseases and cancers with a high unmet medical need. By focusing on the genetic causes of disease, BridgeBio delivers targeted therapies that address underlying conditions. With a robust pipeline of innovative drug candidates, the company strives to transform patient care through cutting-edge research and clinical development, providing hope to those affected by rare and serious illnesses